Indefinite Delivery Contract SPE2DB20D9202

The Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD), awarded a $499,999,999 single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

Under this IDC, the DLA has issued multiple firm fixed-price delivery orders to DMS Pharmaceutical Group for the supply of specialized pharmaceutical items such as Nexplanon, Kyleena, Mirena, YF-VAX, and other contraceptive devices and medications. These delivery orders, ranging from approximately $200 to over $50,000, do not have set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across various medical product categories. The contracted products are being delivered to the DLA's military healthcare facilities located in Park Ridge, Illinois, with performance periods typically lasting between 6 months to 2 years.